Neuronetics, Inc. (STIM) stock
STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.28+0.03 (+2.40%)
Close on Nov 17, 2026Market cap $97.53MP/E –Yield –
Neuronetics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Neuronetics's price to sales ratio was 0.8× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.3× to 3.3×, with a median of 1.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.8× | +0.1 |
| 2025 | Dec 31, 2025 | 0.7× | +0.1 |
| 2024 | Dec 31, 2024 | 0.7× | −0.5 |
| 2023 | Dec 29, 2023 | 1.2× | −1.8 |
| 2022 | Dec 30, 2022 | 3.0× | +0.9 |
| 2021 | Dec 31, 2021 | 2.1× | −2.0 |
| 2020 | Dec 31, 2020 | 4.1× | +2.8 |
| 2019 | Dec 31, 2019 | 1.4× | −5.5 |
| 2018 | Dec 31, 2018 | 6.9× | – |
See a number that looks wrong?